CLBCX
Price
$40.37
Change
+$0.07 (+0.17%)
Updated
Jul 31 closing price
Net Assets
288.09B
MBACX
Price
$33.00
Change
+$0.05 (+0.15%)
Updated
Jul 31 closing price
Net Assets
448.9M
Interact to see
Advertisement

CLBCX vs MBACX

CLBCX vs MBACX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. MBACX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and MBACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 288B vs. MBACX (449M). CLBCX pays higher dividends than MBACX: CLBCX (1.09) vs MBACX (0.90). CLBCX was incepted earlier than MBACX: CLBCX (24 years) vs MBACX (24 years). MBACX (2.18) is less costly to investors than CLBCX (1.35). MBACX is a more actively managed with annual turnover of: 201.00 vs. CLBCX (50.00). CLBCX has a lower initial minimum investment than MBACX: CLBCX (250) vs MBACX (1000). CLBCX annual gain was more profitable for investors over the last year : 10.49 vs. MBACX (8.32). CLBCX return over 5 years is better than : 29.10 vs. MBACX (-4.65).
CLBCXMBACXCLBCX / MBACX
Total Expense Ratio1.352.0865%
Annual Report Gross Expense Ratio1.352.1862%
Fund Existence24 years24 years-
Gain YTD7.9157.069112%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B449M64,143%
Annual Yield % from dividends1.090.90121%
Returns for 1 year10.498.32126%
Returns for 3 years35.5217.94198%
Returns for 5 years29.10-4.65-626%
Returns for 10 years79.3911.45693%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURX0.210.01
+7.32%
Curanex Pharmaceuticals Inc.
UFI6.400.26
+4.23%
UNIFI
MNTN9.22-0.01
-0.11%
MNTN Inc.
BRO70.40-0.47
-0.66%
Brown & Brown
TOWN37.91-0.30
-0.79%
TowneBank